U.S. pharma big copyright scrapped two experimental weight loss capsules last yr—a when-each day tablet, lotiglipron, because of elevated liver enzymes plus a 2 times-daily pill, danuglipron, as a result of sturdy Negative effects—but CEO Albert Bourla has claimed the company is deci